HealthQuill Pharma
Vicebio will receive potential milestone payments of up to $450 million based on development and regulatory achievements.
Drugs Health Pharma

Sanofi to acquire UK’s Vicebio for $1.6b, to pocket vaccine candidates

 HQ Team July 22, 2025: Sanofi SA will acquire UK-based Vicebio Ltd. for $1.6 billion to gain access to vaccine candidates for respiratory.

Read More
Swedish-British AstraZeneca Plc. plans to build a new facility in the US to manufacture drug components for weight management and metabolism, and invest $50 billion in the country over five years.
Drugs Health Pharma

AstraZeneca to invest $50 billion in US, to build new drug facility

HQ Team July 22, 2025: Swedish-British AstraZeneca Plc. plans to build a new facility in the US to manufacture drug components for weight.

Read More
AstraZeneca Plc’s therapy for a certain type of advanced lung cancer, in combination with chemotherapy, helped patients live longer, company data from an end-stage study reveals.
Drugs Health Pharma

AstraZeneca’s therapy for a type of lung cancer helps patients live longer 

HQ Team July 21, 2025: AstraZeneca Plc’s therapy for a certain type of advanced lung cancer, in combination with chemotherapy, helped patients live.

Read More
AstraZeneca Plc’s investigational drug to treat AL amyloidosis, a rare and serious disease affecting the heart and kidneys, failed to meet its main goal of helping people to live longer.
Drugs Health Pharma

AstraZeneca’s trial drug for AL amyloidosis fails to meet survival goal

HQ Team July 16, 2025: AstraZeneca Plc’s investigational drug to treat AL amyloidosis, a rare and serious disease affecting the heart and kidneys,.

Read More
The US Food and Drug Administration has approved a biosimilar product made by India’s Biocon Biologics Ltd., a subsidiary of Biocon Ltd., to treat diabetes mellitus in adults and pediatric patients.
Drugs Health Pharma

US regulator clears Biocon’s diabetic biosimilar product for Novolog

HQ Team July 15, 2025: The US Food and Drug Administration has approved a biosimilar product made by India’s Biocon Biologics Ltd., a.

Read More
ViiV Healthcare, majority owned by GSK, has signed a pact with the UN-backed Medicines Patent Pool (MPP) to enable generic access to its HIV treatment in 133 countries.
Drugs Health Pharma

ViiV to grant generic access to its HIV medicine to benefit 133 nations

HQ Team July 15, 2025: ViiV Healthcare, majority owned by GSK, has signed a pact with the UN-backed Medicines Patent Pool (MPP) to.

Read More
Global infant vaccination rates were up marginally last year, but shortfalls in funding, instability, and rising misinformation threaten to block further progress, the UNICEF stated.
Drugs Health Pharma

Funding shortage, conflicts hinder infant vaccination progress: UNICEF

HQ Team July 15, 2025: Global infant vaccination rates were up marginally last year, but shortfalls in funding, instability, and rising misinformation threaten.

Read More
A patient in Northern Arizona, US, has died from pneumonic plague, the first such death in the country since 2007, according to a government statement.
Drugs Health Pharma

Northern Arizona resident dies of pneumonic plague, first since 2007

HQ Team July 13, 2025: A patient in Northern Arizona, US, has died from pneumonic plague, the first such death in the country.

Read More
AbbVie Inc. and IGI Therapeutics SA have signed a $2 billion licensing agreement that gives AbbVie access to an antibody being tested for certain types of cancers and autoimmune conditions.
Drugs Health Pharma

AbbVie inks $2 billion deal with IGI, bags antibody to fight cancer 

HQ Team July 10, 2025: AbbVie Inc. and IGI Therapeutics SA have signed a $2 billion licensing agreement that gives AbbVie access to.

Read More
Gilead Sciences Inc. and the Global Fund have signed a pact to supply an HIV prevention drug at no profit to benefit two million people in low-income nations.
Drugs Health Pharma

Gilead, Global Fund to supply HIV prevention drug to two million people

HQ Team July 10, 2025: Gilead Sciences Inc. and the Global Fund have signed a pact to supply an HIV prevention drug at.

Read More